Prosecution Insights
Last updated: October 02, 2026
Application No. 18/398,386

CURABLE COMPOSITION, CURED PRODUCT, COATING AGENT, AND CONCRETE STRUCTURE

Non-Final OA §103
Filed
Dec 28, 2023
Priority
Jul 05, 2021 — JP 2021-111413 +1 more
Examiner
JOHNSTON, BRIEANN R
Art Unit
Tech Center
Assignee
Kaneka Corporation
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
1m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
510 granted / 1030 resolved
-10.5% vs TC avg
Strong +32% interview lift
Without
With
+32.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
38 currently pending
Career history
1079
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
52.7%
+12.7% vs TC avg
§102
20.3%
-19.7% vs TC avg
§112
17.7%
-22.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1030 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-9 are rejected under 35 U.S.C. 103 as being unpatentable over Yano (US 8,759,435). Yano teaches a highly transparent cured article comprising the following: (A) a mixture composed of a polyoxypropylene polymer having a reactive silicon group and a (meth)acrylic acid ester polymer having a reactive silicon group, where the silicon group is preferably diethoxymethylsilyl groups (col. 5, ll. 26-39), and the (meth)acrylic acid ester polymer is taught as comprising (meth)acrylic acid ester monomers, preferably using butyl acrylate, ethyl acrylate, and 2-methoxyethyl acrylate/2-ethoxyethyl acrylate, specifically a copolymer of ethyl acrylate/butyl acrylate/2-methoxyethyl (ratio by weight of 40-50/20-30/30-20) (col. 9, l. 4 to col. 10, l. 34); (D) 1-250 parts, preferably 10-200 phr silica, and 0.1-150 phr of a plasticizer, specifically listed to include phthalic acid esters, phosphates, trimellitic acid esters, etc. (col. 21, l. 51 to col. 23, l. 24) and exemplified as diisodecyl phthalate in Example 7 (col. 37), which is an aromatic acid ester plasticizer. Yano exemplifies the polyoxyproyplene as having a number average molecular weight of 25,500 (col. 29, ll. 9-37). The amount of plasticizer taught by Yano overlaps with the claimed range of at least 60 phr, and it has been held that overlapping ranges are sufficient to establish prima facie obviousness. See MPEP 2144.05. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to have selected from the overlapping portion of the range taught by the reference because overlapping ranges have been held to establish prima facie obviousness. As to the haze, Yano prefers the composition to be transparent, and Yano exemplifies a haze of 23% as being satisfactory (col. 37, Example 7). While the haze is not measured as claimed, one of ordinary skill in the art would expect the haze to be low, as claimed, as Yano teaches the claimed components in the claimed amounts. Yano is prima facie obvious over instant claims 1-5 and 8-9. As to claims 6-7, Yano teaches that the method for synthesizing the (meth)acrylate acid ester polymers is not limited but is preferably a living radical polymerization method, where the crosslinkable functional group is at its molecular chain terminal, in view of the polymer having a narrow molecular wight distribution and a low viscosity (col. 10, ll. 35-61), where the crosslinkable group is the hydrolysable silicon-containing group. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRIEANN R JOHNSTON whose telephone number is (571)270-7344. The examiner can normally be reached Monday-Friday, 8:00 AM - 4:00 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Randy Gulakowski can be reached at (571)272-1302. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Brieann R Johnston/Primary Examiner, Art Unit 1766
Read full office action

Prosecution Timeline

Dec 28, 2023
Application Filed
Sep 01, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742057
BORON NITRIDE PARTICLES, RESIN COMPOSITION, AND METHOD FOR PRODUCING RESIN COMPOSITION
3y 7m to grant Granted Sep 22, 2026
Patent 12728593
FUSING AGENTS WITH TRIAZINE RADIATION ABSORBERS FOR THREE-DIMENSIONAL PRINTING
2y 8m to grant Granted Sep 08, 2026
Patent 12692360
FLAME RETARDANT CHEMICAL COMPOSITIONS
3y 12m to grant Granted Jul 28, 2026
Patent 12686799
WATER-DISPERSED PRESSURE-SENSITIVE ADHESIVE COMPOSITION
4y 0m to grant Granted Jul 21, 2026
Patent 12679918
COPOLYMER FOR POLYMER ELECTROLYTE, AND GEL POLYMER ELECTROLYTE AND LITHIUM SECONDARY BATTERY WHICH INCLUDE THE SAME
4y 7m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
82%
With Interview (+32.5%)
2y 10m (~1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1030 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month